
Owlet, Inc. (NYSE: OWLT) Stock Competitors & Peer Comparison
See OWLT's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for OWLT and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| OWLT | $6.27 | +7.92% | 114.5M | -45.21 | -$0.14 | N/A |
| ABT | $111.27 | +0.32% | 192.6B | 21.36 | $5.21 | +2.23% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| SYK | $341.09 | -1.76% | 130.8B | 25.47 | $13.39 | +1.02% |
| MDT | $90.58 | -0.20% | 116B | 16.38 | $5.53 | +3.14% |
| BSX | $51.69 | +0.53% | 76.9B | 16.68 | $3.10 | N/A |
| EW | $92.56 | -0.53% | 53.3B | 34.29 | $2.70 | N/A |
| DXCM | $91.48 | +0.75% | 34.5B | 39.26 | $2.33 | N/A |
| RMD | $226.74 | +0.33% | 32.9B | 21.06 | $10.77 | +1.05% |
| PHG | $27.38 | +2.16% | 26.8B | 15.64 | $1.75 | +3.62% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
OWLT vs ABT Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, ABT has a market cap of 192.6B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while ABT trades at $111.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas ABT's P/E ratio is 21.36. In terms of profitability, OWLT's ROE is -0.50%, compared to ABT's ROE of +0.11%. Regarding short-term risk, OWLT is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
OWLT vs BSX-PA Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, OWLT's ROE is -0.50%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, OWLT is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BSX-PA's competition here
Stryker Corporation (NYSE: SYK)
OWLT vs SYK Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, SYK has a market cap of 130.8B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while SYK trades at $341.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas SYK's P/E ratio is 25.47. In terms of profitability, OWLT's ROE is -0.50%, compared to SYK's ROE of +0.16%. Regarding short-term risk, OWLT is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SYK's competition here
Medtronic plc (NYSE: MDT)
OWLT vs MDT Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, MDT has a market cap of 116B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while MDT trades at $90.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas MDT's P/E ratio is 16.38. In terms of profitability, OWLT's ROE is -0.50%, compared to MDT's ROE of +0.10%. Regarding short-term risk, OWLT is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
OWLT vs BSX Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, BSX has a market cap of 76.9B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while BSX trades at $51.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas BSX's P/E ratio is 16.68. In terms of profitability, OWLT's ROE is -0.50%, compared to BSX's ROE of +0.15%. Regarding short-term risk, OWLT is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
OWLT vs EW Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, EW has a market cap of 53.3B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while EW trades at $92.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas EW's P/E ratio is 34.29. In terms of profitability, OWLT's ROE is -0.50%, compared to EW's ROE of +0.10%. Regarding short-term risk, OWLT is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
OWLT vs DXCM Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, DXCM has a market cap of 34.5B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while DXCM trades at $91.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas DXCM's P/E ratio is 39.26. In terms of profitability, OWLT's ROE is -0.50%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, OWLT is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check DXCM's competition here
ResMed Inc. (NYSE: RMD)
OWLT vs RMD Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, RMD has a market cap of 32.9B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while RMD trades at $226.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas RMD's P/E ratio is 21.06. In terms of profitability, OWLT's ROE is -0.50%, compared to RMD's ROE of +0.24%. Regarding short-term risk, OWLT is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check RMD's competition here
Koninklijke Philips N.V. (NYSE: PHG)
OWLT vs PHG Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, PHG has a market cap of 26.8B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while PHG trades at $27.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas PHG's P/E ratio is 15.64. In terms of profitability, OWLT's ROE is -0.50%, compared to PHG's ROE of +0.10%. Regarding short-term risk, OWLT is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
OWLT vs ZBH Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, ZBH has a market cap of 19.3B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while ZBH trades at $99.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas ZBH's P/E ratio is 11.74. In terms of profitability, OWLT's ROE is -0.50%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, OWLT is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
OWLT vs ABMD Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas ABMD's P/E ratio is 65.36. In terms of profitability, OWLT's ROE is -0.50%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, OWLT is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
OWLT vs PEN Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, PEN has a market cap of 12.9B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while PEN trades at $326.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas PEN's P/E ratio is 85.36. In terms of profitability, OWLT's ROE is -0.50%, compared to PEN's ROE of +0.11%. Regarding short-term risk, OWLT is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
OWLT vs SNN Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, SNN has a market cap of 12.7B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while SNN trades at $30.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas SNN's P/E ratio is 14.17. In terms of profitability, OWLT's ROE is -0.50%, compared to SNN's ROE of +0.12%. Regarding short-term risk, OWLT is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
OWLT vs ALGN Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, ALGN has a market cap of 12.6B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while ALGN trades at $176.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas ALGN's P/E ratio is 16.06. In terms of profitability, OWLT's ROE is -0.50%, compared to ALGN's ROE of +0.14%. Regarding short-term risk, OWLT is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ALGN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
OWLT vs SWAV Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas SWAV's P/E ratio is 78.76. In terms of profitability, OWLT's ROE is -0.50%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, OWLT is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SWAV's competition here
Globus Medical, Inc. (NYSE: GMED)
OWLT vs GMED Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, GMED has a market cap of 11.6B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while GMED trades at $85.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas GMED's P/E ratio is 19.36. In terms of profitability, OWLT's ROE is -0.50%, compared to GMED's ROE of +0.12%. Regarding short-term risk, OWLT is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check GMED's competition here
Glaukos Corporation (NYSE: GKOS)
OWLT vs GKOS Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, GKOS has a market cap of 11.2B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while GKOS trades at $189.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas GKOS's P/E ratio is -220.30. In terms of profitability, OWLT's ROE is -0.50%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, OWLT is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check GKOS's competition here
Insulet Corp. (NASDAQ: PODD)
OWLT vs PODD Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, PODD has a market cap of 10.1B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while PODD trades at $146.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas PODD's P/E ratio is 24.95. In terms of profitability, OWLT's ROE is -0.50%, compared to PODD's ROE of +0.27%. Regarding short-term risk, OWLT is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check PODD's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
OWLT vs BIO Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, BIO has a market cap of 9.7B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while BIO trades at $361.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas BIO's P/E ratio is 38.93. In terms of profitability, OWLT's ROE is -0.50%, compared to BIO's ROE of +0.03%. Regarding short-term risk, OWLT is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BIO's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
OWLT vs BIO-B Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, BIO-B has a market cap of 9.5B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while BIO-B trades at $348.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas BIO-B's P/E ratio is 103.33. In terms of profitability, OWLT's ROE is -0.50%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, OWLT is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BIO-B's competition here
Masimo Corporation (NASDAQ: MASI)
OWLT vs MASI Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas MASI's P/E ratio is 44.43. In terms of profitability, OWLT's ROE is -0.50%, compared to MASI's ROE of +0.09%. Regarding short-term risk, OWLT is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
OWLT vs BRKR Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, BRKR has a market cap of 8.8B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while BRKR trades at $57.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas BRKR's P/E ratio is 29.11. In terms of profitability, OWLT's ROE is -0.50%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, OWLT is more volatile compared to BRKR. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BRKR's competition here
Inari Medical, Inc. (NASDAQ: NARI)
OWLT vs NARI Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas NARI's P/E ratio is -59.24. In terms of profitability, OWLT's ROE is -0.50%, compared to NARI's ROE of -0.00%. Regarding short-term risk, OWLT is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check NARI's competition here
LivaNova PLC (NASDAQ: LIVN)
OWLT vs LIVN Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, LIVN has a market cap of 4.4B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while LIVN trades at $82.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas LIVN's P/E ratio is 19.19. In terms of profitability, OWLT's ROE is -0.50%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, OWLT is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check LIVN's competition here
Integer Holdings Corporation (NYSE: ITGR)
OWLT vs ITGR Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, ITGR has a market cap of 4.2B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while ITGR trades at $125.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas ITGR's P/E ratio is 19.69. In terms of profitability, OWLT's ROE is -0.50%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, OWLT is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ITGR's competition here
Haemonetics Corporation (NYSE: HAE)
OWLT vs HAE Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, HAE has a market cap of 4.1B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while HAE trades at $90.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas HAE's P/E ratio is 18.06. In terms of profitability, OWLT's ROE is -0.50%, compared to HAE's ROE of +0.11%. Regarding short-term risk, OWLT is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check HAE's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
OWLT vs IRTC Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, IRTC has a market cap of 4B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while IRTC trades at $123.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas IRTC's P/E ratio is -192.44. In terms of profitability, OWLT's ROE is -0.50%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, OWLT is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
OWLT vs AXNX Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas AXNX's P/E ratio is -709.80. In terms of profitability, OWLT's ROE is -0.50%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, OWLT is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
OWLT vs TMDX Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, TMDX has a market cap of 3.1B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while TMDX trades at $89.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas TMDX's P/E ratio is 45.50. In terms of profitability, OWLT's ROE is -0.50%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, OWLT is more volatile compared to TMDX. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
OWLT vs AXGN Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, AXGN has a market cap of 2.6B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while AXGN trades at $48.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas AXGN's P/E ratio is 126.45. In terms of profitability, OWLT's ROE is -0.50%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, OWLT is more volatile compared to AXGN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
OWLT vs UFPT Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, UFPT has a market cap of 2.5B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while UFPT trades at $319.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas UFPT's P/E ratio is 32.67. In terms of profitability, OWLT's ROE is -0.50%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, OWLT is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
OWLT vs BFLY Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, BFLY has a market cap of 2.4B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while BFLY trades at $8.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas BFLY's P/E ratio is -36.79. In terms of profitability, OWLT's ROE is -0.50%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, OWLT is more volatile compared to BFLY. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BFLY's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
OWLT vs ESTA Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, ESTA has a market cap of 2.2B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while ESTA trades at $75.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas ESTA's P/E ratio is -59.99. In terms of profitability, OWLT's ROE is -0.50%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, OWLT is more volatile compared to ESTA. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ESTA's competition here
NuVasive, Inc. (NASDAQ: NUVA)
OWLT vs NUVA Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas NUVA's P/E ratio is 75.00. In terms of profitability, OWLT's ROE is -0.50%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, OWLT is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check NUVA's competition here
Novocure Ltd (NASDAQ: NVCR)
OWLT vs NVCR Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, NVCR has a market cap of 2B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while NVCR trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas NVCR's P/E ratio is -11.36. In terms of profitability, OWLT's ROE is -0.50%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, OWLT is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check NVCR's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
OWLT vs INSP Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, INSP has a market cap of 1.7B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while INSP trades at $58.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas INSP's P/E ratio is 25.62. In terms of profitability, OWLT's ROE is -0.50%, compared to INSP's ROE of +0.18%. Regarding short-term risk, OWLT is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check INSP's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
OWLT vs TNDM Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, TNDM has a market cap of 1.6B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while TNDM trades at $23.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas TNDM's P/E ratio is -21.03. In terms of profitability, OWLT's ROE is -0.50%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, OWLT is more volatile compared to TNDM. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check TNDM's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
OWLT vs ATEC Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, ATEC has a market cap of 1.5B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while ATEC trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas ATEC's P/E ratio is -162.50. In terms of profitability, OWLT's ROE is -0.50%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, OWLT is more volatile compared to ATEC. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
OWLT vs CNMD Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while CNMD trades at $49.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas CNMD's P/E ratio is 10.94. In terms of profitability, OWLT's ROE is -0.50%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, OWLT is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check CNMD's competition here
Enovis Corporation (NYSE: ENOV)
OWLT vs ENOV Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, ENOV has a market cap of 1.5B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while ENOV trades at $25.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas ENOV's P/E ratio is 7.36. In terms of profitability, OWLT's ROE is -0.50%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, OWLT is more volatile compared to ENOV. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ENOV's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
OWLT vs IART Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, IART has a market cap of 1.4B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while IART trades at $18.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas IART's P/E ratio is 7.73. In terms of profitability, OWLT's ROE is -0.50%, compared to IART's ROE of -0.01%. Regarding short-term risk, OWLT is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check IART's competition here
Artivion, Inc. (NYSE: AORT)
OWLT vs AORT Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, AORT has a market cap of 1.4B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while AORT trades at $28.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas AORT's P/E ratio is 47.38. In terms of profitability, OWLT's ROE is -0.50%, compared to AORT's ROE of -0.01%. Regarding short-term risk, OWLT is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check AORT's competition here
Heska Corporation (NASDAQ: HSKA)
OWLT vs HSKA Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas HSKA's P/E ratio is -62.49. In terms of profitability, OWLT's ROE is -0.50%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, OWLT is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check HSKA's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
OWLT vs PRCT Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while PRCT trades at $21.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas PRCT's P/E ratio is -11.31. In terms of profitability, OWLT's ROE is -0.50%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, OWLT is more volatile compared to PRCT. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check PRCT's competition here
Avanos Medical, Inc. (NYSE: AVNS)
OWLT vs AVNS Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas AVNS's P/E ratio is 27.77. In terms of profitability, OWLT's ROE is -0.50%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, OWLT is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check AVNS's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
OWLT vs LMRI Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while LMRI trades at $12.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas LMRI's P/E ratio is -22.82. In terms of profitability, OWLT's ROE is -0.50%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, OWLT is more volatile compared to LMRI. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check LMRI's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
OWLT vs SILK Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas SILK's P/E ratio is -18.96. In terms of profitability, OWLT's ROE is -0.50%, compared to SILK's ROE of -0.35%. Regarding short-term risk, OWLT is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SILK's competition here
IRadimed Corporation (NASDAQ: IRMD)
OWLT vs IRMD Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while IRMD trades at $87.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas IRMD's P/E ratio is 43.80. In terms of profitability, OWLT's ROE is -0.50%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, OWLT is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check IRMD's competition here
Paragon 28, Inc. (NYSE: FNA)
OWLT vs FNA Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas FNA's P/E ratio is -19.83. In terms of profitability, OWLT's ROE is -0.50%, compared to FNA's ROE of -0.35%. Regarding short-term risk, OWLT is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check FNA's competition here
Bioventus Inc. (NASDAQ: BVS)
OWLT vs BVS Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, BVS has a market cap of 941M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while BVS trades at $13.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas BVS's P/E ratio is 18.28. In terms of profitability, OWLT's ROE is -0.50%, compared to BVS's ROE of +0.28%. Regarding short-term risk, OWLT is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
OWLT vs CBLL Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, CBLL has a market cap of 882.2M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while CBLL trades at $23.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas CBLL's P/E ratio is -14.26. In terms of profitability, OWLT's ROE is -0.50%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, OWLT is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check CBLL's competition here
InMode Ltd. (NASDAQ: INMD)
OWLT vs INMD Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, INMD has a market cap of 873.7M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while INMD trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas INMD's P/E ratio is 10.56. In terms of profitability, OWLT's ROE is -0.50%, compared to INMD's ROE of +0.12%. Regarding short-term risk, OWLT is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check INMD's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
OWLT vs AVR Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, AVR has a market cap of 868.3M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while AVR trades at $8.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas AVR's P/E ratio is -4.00. In terms of profitability, OWLT's ROE is -0.50%, compared to AVR's ROE of -0.78%. Regarding short-term risk, OWLT is more volatile compared to AVR. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check AVR's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
OWLT vs CSII Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas CSII's P/E ratio is -20.83. In terms of profitability, OWLT's ROE is -0.50%, compared to CSII's ROE of -0.14%. Regarding short-term risk, OWLT is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
OWLT vs SIBN Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, SIBN has a market cap of 840.4M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while SIBN trades at $18.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas SIBN's P/E ratio is -55.74. In terms of profitability, OWLT's ROE is -0.50%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, OWLT is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SIBN's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
OWLT vs BBNX Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, BBNX has a market cap of 813.4M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while BBNX trades at $18.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas BBNX's P/E ratio is -11.97. In terms of profitability, OWLT's ROE is -0.50%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, OWLT is more volatile compared to BBNX. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BBNX's competition here
Varex Imaging Corporation (NASDAQ: VREX)
OWLT vs VREX Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, VREX has a market cap of 778.9M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while VREX trades at $18.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas VREX's P/E ratio is 19.47. In terms of profitability, OWLT's ROE is -0.50%, compared to VREX's ROE of +0.05%. Regarding short-term risk, OWLT is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check VREX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
OWLT vs AHCO Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, AHCO has a market cap of 775.5M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while AHCO trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas AHCO's P/E ratio is 11.63. In terms of profitability, OWLT's ROE is -0.50%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, OWLT is more volatile compared to AHCO. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check AHCO's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
OWLT vs SSII Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, SSII has a market cap of 766.5M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while SSII trades at $3.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas SSII's P/E ratio is -74.70. In terms of profitability, OWLT's ROE is -0.50%, compared to SSII's ROE of -0.27%. Regarding short-term risk, OWLT is more volatile compared to SSII. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SSII's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
OWLT vs BWAY Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, BWAY has a market cap of 646M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while BWAY trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas BWAY's P/E ratio is 41.84. In terms of profitability, OWLT's ROE is -0.50%, compared to BWAY's ROE of +0.12%. Regarding short-term risk, OWLT is more volatile compared to BWAY. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BWAY's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
OWLT vs KIDS Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, KIDS has a market cap of 642.4M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while KIDS trades at $25.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas KIDS's P/E ratio is -21.19. In terms of profitability, OWLT's ROE is -0.50%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, OWLT is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check KIDS's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
OWLT vs CTKB Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, CTKB has a market cap of 631.5M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while CTKB trades at $4.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas CTKB's P/E ratio is -25.91. In terms of profitability, OWLT's ROE is -0.50%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, OWLT is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check CTKB's competition here
Surmodics, Inc. (NASDAQ: SRDX)
OWLT vs SRDX Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas SRDX's P/E ratio is -34.66. In terms of profitability, OWLT's ROE is -0.50%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, OWLT is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SRDX's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
OWLT vs DCTH Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, DCTH has a market cap of 599.3M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while DCTH trades at $17.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas DCTH's P/E ratio is 1736.00. In terms of profitability, OWLT's ROE is -0.50%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, OWLT is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check DCTH's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
OWLT vs APEN Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas APEN's P/E ratio is -9.43. In terms of profitability, OWLT's ROE is -0.50%, compared to APEN's ROE of -0.85%. Regarding short-term risk, OWLT is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check APEN's competition here
Cerus Corporation (NASDAQ: CERS)
OWLT vs CERS Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, CERS has a market cap of 572.3M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while CERS trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas CERS's P/E ratio is -56.69. In terms of profitability, OWLT's ROE is -0.50%, compared to CERS's ROE of -0.10%. Regarding short-term risk, OWLT is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check CERS's competition here
ZimVie Inc. (NASDAQ: ZIMV)
OWLT vs ZIMV Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, OWLT's ROE is -0.50%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, OWLT is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ZIMV's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
OWLT vs TCMD Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, TCMD has a market cap of 534.8M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while TCMD trades at $23.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas TCMD's P/E ratio is 26.94. In terms of profitability, OWLT's ROE is -0.50%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, OWLT is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check TCMD's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
OWLT vs NPCE Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, NPCE has a market cap of 494.7M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while NPCE trades at $14.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas NPCE's P/E ratio is -22.32. In terms of profitability, OWLT's ROE is -0.50%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, OWLT is more volatile compared to NPCE. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check NPCE's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
OWLT vs CLPT Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, CLPT has a market cap of 462.4M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while CLPT trades at $15.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas CLPT's P/E ratio is -13.07. In terms of profitability, OWLT's ROE is -0.50%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, OWLT is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check CLPT's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
OWLT vs SGHT Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, SGHT has a market cap of 452.7M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while SGHT trades at $8.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas SGHT's P/E ratio is -14.86. In terms of profitability, OWLT's ROE is -0.50%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, OWLT is more volatile compared to SGHT. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SGHT's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
OWLT vs OFIX Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, OFIX has a market cap of 411.5M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while OFIX trades at $10.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas OFIX's P/E ratio is -13.30. In terms of profitability, OWLT's ROE is -0.50%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, OWLT is more volatile compared to OFIX. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check OFIX's competition here
Carlsmed, Inc. (NASDAQ: CARL)
OWLT vs CARL Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, CARL has a market cap of 380.3M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while CARL trades at $13.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas CARL's P/E ratio is -9.78. In terms of profitability, OWLT's ROE is -0.50%, compared to CARL's ROE of -0.38%. Regarding short-term risk, OWLT is more volatile compared to CARL. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check CARL's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
OWLT vs PACB Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, PACB has a market cap of 357.2M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while PACB trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas PACB's P/E ratio is -2.80. In terms of profitability, OWLT's ROE is -0.50%, compared to PACB's ROE of -49.62%. Regarding short-term risk, OWLT is more volatile compared to PACB. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check PACB's competition here
Picard Medical, Inc. (AMEX: PMI)
OWLT vs PMI Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, PMI has a market cap of 354.8M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while PMI trades at $3.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas PMI's P/E ratio is -2.88. In terms of profitability, OWLT's ROE is -0.50%, compared to PMI's ROE of +4.99%. Regarding short-term risk, OWLT is more volatile compared to PMI. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check PMI's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
OWLT vs CATX Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, CATX has a market cap of 352.4M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while CATX trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas CATX's P/E ratio is -2.19. In terms of profitability, OWLT's ROE is -0.50%, compared to CATX's ROE of -0.42%. Regarding short-term risk, OWLT is more volatile compared to CATX. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check CATX's competition here
Electromed, Inc. (AMEX: ELMD)
OWLT vs ELMD Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, ELMD has a market cap of 351.1M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while ELMD trades at $42.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas ELMD's P/E ratio is 36.24. In terms of profitability, OWLT's ROE is -0.50%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, OWLT is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ELMD's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
OWLT vs TLSI Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, TLSI has a market cap of 346.7M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while TLSI trades at $5.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas TLSI's P/E ratio is -3.35. In terms of profitability, OWLT's ROE is -0.50%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, OWLT is more volatile compared to TLSI. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check TLSI's competition here
CapsoVision, Inc. (NASDAQ: CV)
OWLT vs CV Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, CV has a market cap of 339.3M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while CV trades at $6.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas CV's P/E ratio is -2.72. In terms of profitability, OWLT's ROE is -0.50%, compared to CV's ROE of +1.27%. Regarding short-term risk, OWLT is more volatile compared to CV. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check CV's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
OWLT vs SENS Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, SENS has a market cap of 323.1M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while SENS trades at $7.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas SENS's P/E ratio is -3.86. In terms of profitability, OWLT's ROE is -0.50%, compared to SENS's ROE of -1.66%. Regarding short-term risk, OWLT is more volatile compared to SENS. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SENS's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
OWLT vs SMLR Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas SMLR's P/E ratio is 3.92. In terms of profitability, OWLT's ROE is -0.50%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, OWLT is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
OWLT vs TMCI Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, TMCI has a market cap of 292.6M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while TMCI trades at $4.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas TMCI's P/E ratio is -4.80. In terms of profitability, OWLT's ROE is -0.50%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, OWLT is more volatile compared to TMCI. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check TMCI's competition here
RxSight, Inc. (NASDAQ: RXST)
OWLT vs RXST Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, RXST has a market cap of 290.2M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while RXST trades at $7.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas RXST's P/E ratio is -7.54. In terms of profitability, OWLT's ROE is -0.50%, compared to RXST's ROE of -0.17%. Regarding short-term risk, OWLT is more volatile compared to RXST. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check RXST's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
OWLT vs ANIK Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, ANIK has a market cap of 283.3M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while ANIK trades at $21.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas ANIK's P/E ratio is 43.20. In terms of profitability, OWLT's ROE is -0.50%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, OWLT is more volatile compared to ANIK. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ANIK's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
OWLT vs MGRM Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas MGRM's P/E ratio is -12.00. In terms of profitability, OWLT's ROE is -0.50%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, OWLT is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check MGRM's competition here
Profound Medical Corp. (NASDAQ: PROF)
OWLT vs PROF Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, PROF has a market cap of 242.4M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while PROF trades at $6.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas PROF's P/E ratio is -5.38. In terms of profitability, OWLT's ROE is -0.50%, compared to PROF's ROE of -0.56%. Regarding short-term risk, OWLT is more volatile compared to PROF. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check PROF's competition here
Nevro Corp. (NYSE: NVRO)
OWLT vs NVRO Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas NVRO's P/E ratio is -1.91. In terms of profitability, OWLT's ROE is -0.50%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, OWLT is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check NVRO's competition here
Neuronetics, Inc. (NASDAQ: STIM)
OWLT vs STIM Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, STIM has a market cap of 210.9M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while STIM trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas STIM's P/E ratio is -5.61. In terms of profitability, OWLT's ROE is -0.50%, compared to STIM's ROE of -1.51%. Regarding short-term risk, OWLT is more volatile compared to STIM. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check STIM's competition here
Avita Medical Inc. (NASDAQ: RCEL)
OWLT vs RCEL Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, RCEL has a market cap of 199M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while RCEL trades at $8.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas RCEL's P/E ratio is -5.10. In terms of profitability, OWLT's ROE is -0.50%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, OWLT is more volatile compared to RCEL. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check RCEL's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
OWLT vs BSGM Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas BSGM's P/E ratio is -5.81. In terms of profitability, OWLT's ROE is -0.50%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, OWLT is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check BSGM's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
OWLT vs LUCD Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, LUCD has a market cap of 184.1M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while LUCD trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas LUCD's P/E ratio is -2.61. In terms of profitability, OWLT's ROE is -0.50%, compared to LUCD's ROE of -0.02%. Regarding short-term risk, OWLT is more volatile compared to LUCD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check LUCD's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
OWLT vs MDGS Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas MDGS's P/E ratio is -0.27. In terms of profitability, OWLT's ROE is -0.50%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, OWLT is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check MDGS's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
OWLT vs FOCL Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, FOCL has a market cap of 178M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while FOCL trades at $4.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas FOCL's P/E ratio is -5.80. In terms of profitability, OWLT's ROE is -0.50%, compared to FOCL's ROE of -1.38%. Regarding short-term risk, OWLT is more volatile compared to FOCL. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check FOCL's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
OWLT vs QIPT Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas QIPT's P/E ratio is -15.87. In terms of profitability, OWLT's ROE is -0.50%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, OWLT is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check QIPT's competition here
Inogen, Inc. (NASDAQ: INGN)
OWLT vs INGN Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, INGN has a market cap of 157.3M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while INGN trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas INGN's P/E ratio is -6.38. In terms of profitability, OWLT's ROE is -0.50%, compared to INGN's ROE of -0.13%. Regarding short-term risk, OWLT is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
OWLT vs QTRX Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, QTRX has a market cap of 134.7M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while QTRX trades at $2.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas QTRX's P/E ratio is -1.79. In terms of profitability, OWLT's ROE is -0.50%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, OWLT is more volatile compared to QTRX. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check QTRX's competition here
iCAD, Inc. (NASDAQ: ICAD)
OWLT vs ICAD Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas ICAD's P/E ratio is -20.37. In terms of profitability, OWLT's ROE is -0.50%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, OWLT is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ICAD's competition here
Solana Company (NASDAQ: HSDT)
OWLT vs HSDT Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, HSDT has a market cap of 105.1M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while HSDT trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas HSDT's P/E ratio is -0.02. In terms of profitability, OWLT's ROE is -0.50%, compared to HSDT's ROE of -1.55%. Regarding short-term risk, OWLT is more volatile compared to HSDT. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check HSDT's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
OWLT vs HJLI Comparison August 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 114.5M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, OWLT is priced at $6.27 on the NYSE, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -45.21, whereas HJLI's P/E ratio is N/A. In terms of profitability, OWLT's ROE is -0.50%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, OWLT is more volatile compared to HJLI. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check HJLI's competition here